14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
EVCM vs SGHT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, EverCommerce Inc. (EVCM) is the stronger overall head-to-head candidate over Sight Sciences, Inc. (SGHT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EVCM carries a Unified Composite Score of 42.7/100 (HOLD) at $6.21 (9.2x Forward P/E, 9.5% operating margin), whereas SGHT carries 35.1/100 (SELL) at $10.59 (N/M Forward P/E, -20.2% operating margin).
Growth vs. Quality Trade-Off: EVCM earns the overall head-to-head edge with a stronger Unified Composite Score (42.7/100 HOLD vs. SGHT 35.1/100 SELL) and 0.68β · 62% Vol risk profile, whereas SGHT leads top-line expansion (+25.2% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: EVCM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.5); meanwhile SGHT trades in a Markup technical trend (BREAKOUT options phase, RSI 64.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVCM vs SGHT. Trailing 12-month operating profitability (EVCM 9.5% vs SGHT -20.2%) and valuation multiples (EVCM 9.2x vs SGHT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Devices value chain with $610.8M market capitalization and -20.2% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ EVCM vs SGHT Key Questions & Quantitative Answers
As of Nov 16, 2026, EverCommerce Inc. (EVCM) is the stronger overall head-to-head candidate over Sight Sciences, Inc. (SGHT) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). EVCM carries a Unified Composite Score of 42.7/100 (HOLD) at $6.21 (9.2x Forward P/E, 9.5% operating margin), whereas SGHT carries 35.1/100 (SELL) at $10.59 (N/M Forward P/E, -20.2% operating margin). Growth vs. Quality Trade-Off: EVCM earns the overall head-to-head edge with a stronger Unified Composite Score (42.7/100 HOLD vs. SGHT 35.1/100 SELL) and 0.68β · 62% Vol risk profile, whereas SGHT leads top-line expansion (+25.2% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: EVCM is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 22.5); meanwhile SGHT trades in a Markup technical trend (BREAKOUT options phase, RSI 64.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SGHT leads the Growth & Scale pillar: EVCM posts +2.7% YoY revenue growth and -49.1% YoY earnings growth on $602M TTM revenue (78.3% gross margin, 9.5% operating margin), compared with SGHT at +25.2% YoY revenue growth and +0.0% YoY earnings growth on $88M TTM revenue (87.7% gross margin, -20.2% operating margin). On trailing 12-month operating scale, EVCM generates $602M in USD-normalized revenue versus $88M for SGHT. In operating R&D and SG&A reinvestment, EVCM deploys 68.8% of Rev ($414M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SGHT.
EVCM screens cheaper on headline valuation multiples. EVCM trades at 9.2x Forward P/E, 43.6x Trailing P/E, 0.30x PEG, and 2.0x EV/Revenue (17.5% EBITDA margin), whereas SGHT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 6.5x EV/Revenue (-19.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVCM (4.0% ROE) versus SGHT (-50.1% ROE) capital efficiency.
In options market volatility and institutional positioning, EVCM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.68β · 62% Vol realized risk). By comparison, SGHT carries 78.7% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (1.06β · 46% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.